| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 University de Paris Pierre et Marie Curie, Service de Pneumologie et Réanimation, Hôtel-Dieu de Paris, Paris, 2 University de Limoges, Service de Pneumologie et Service de l'information médicale et de l'évaluation, Hôpital du Cluzeau, Limoges, 3 Laboratoire INSERM U408, Faculté de Médecine Xavier Bichat, Paris, 5 GlaxoSmithKline, Marly-Le-Roi, and 6 University de Limoges, Unité de Biostatistique, Service de l'information médicale et de l'évaluation, Hôpital du Cluzeau, Limoges, France
CORRESPONDENCE: G.J. Huchon, Service de Pneumologie et Réanimation, Hôtel-Dieu de Paris, 1 Parvis Notre Dame, F-75181, Paris 04, France. Fax: 33 142348448. E-mail: gerard.huchon@htd.ap-hop-paris.fr
Keywords: chronic obstructive pulmonary disease, comorbidity, lung function, smoking, survey
Received: January 3, 2002
Accepted May 29, 2002
This study was supported by grants from GlaxoSmithKline and Association pour l'Etude de la Respiration et de l'Environnement.
The aims of this survey were to determine the prevalence of symptoms indicative of chronic bronchitis (CB) in the French adult population, to identify the role of risk factors for CB, and to assess rates of CB diagnosis and pulmonary function testing (PFT) in the presence of CB.
A representative sample of 14,076 individuals aged
The prevalence of CB was 4.1% and the prevalence of chronic cough and/or expectoration was 11.7%. In individuals with comorbidity, these figures were 10.4% and 24.4%, respectively. Smoking was associated with an increased frequency of CB. In subjects with CB, 44.6% had PFT (spirometry or peak expiratory flow measurement), 24% were diagnosed as having CB, and 7.2% received care. Rates of diagnosis, PFT, and follow-up were lower in young individuals and in those without comorbidity. PFT and follow-up were less common in current smokers.
Prevalence of chronic bronchitis in French adults is high and similar in magnitude to that of other industrialised countries. Comorbidities and tobacco smoking increase the frequency of chronic bronchitis symptoms. Chronic bronchitis is too infrequently diagnosed, investigated and cared for.
25 yrs completed a self-administered questionnaire on symptoms, comorbidities, smoking history, sociodemographical data, and diagnosis and care by physicians.
This article has been cited by other articles:
|
|
 |
|
  L Shahab, M J Jarvis, J Britton, and R West Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample Thorax, December 1, 2006; 61(12): 1043 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Fuhrman, E Jougla, J Nicolau, D Eilstein, and M-C Delmas Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis Thorax, November 1, 2006; 61(11): 930 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Halbert, J. L. Natoli, A. Gano, E. Badamgarav, A. S. Buist, and D. M. Mannino Global burden of COPD: systematic review and meta-analysis Eur. Respir. J., September 1, 2006; 28(3): 523 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1s - 44s. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
